Bifonazole/Benzoic Acid/Salicylic acid

联苯苄唑/苯甲酸/水杨酸

Report date: 2025/07/22 15:55:34

Base Information

Drug NameBifonazole/Benzoic Acid/Salicylic acid
Drug Alias Name复方联苯苄唑溶液复方联苯苄唑乳膏
ClassificationSmall molecules
Mechanisms of ActionLanosterol 14α-demethylase inhibitorsD-amino-acid oxidase inhibitorsCyclooxygenases inhibitors
TargetsLanosterol 14α-demethylaseD-amino-acid oxidaseCyclooxygenases
Therapy Area/IndicationsDermatomycoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes BifonazoleBenzoic AcidSalicylic acid
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsDermatomycoses
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A